SCHEMBL13046243

SCHEMBL13046243

c1ccc(-c2c3ccccc3c(-c3ccccc3)c3cc(-c4cccc(-c5cc6ccc(-c7ccccn7)nc6c6nc(-c7ccccn7)ccc56)c4)ccc23)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.37
KDM4E B2RXH2 4/20 0.37
TP53 P04637 3/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
MAPK1 P28482 2/20 0.37
CCR1 P32246 2/20 0.37
CCR5 P51681 2/20 0.37
CCR8 P51685 2/20 0.37
ALOX15 P16050 2/20 0.37
HTT P42858 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
ALPL P05186 1/20 0.37
HSP90AA1 P07900 1/20 0.37
ALPI P09923 1/20 0.37
ALPG P10696 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
PIK3CD O00329 1/20 0.34
HSD17B10 Q99714 3/20 0.34
HPGD P15428 3/20 0.34
TSHR P16473 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13046196 0.94 LMNA (0.40) LMNAKDM4ETP53SMN1; SMN2MAPK1
SCHEMBL24783508 0.89 KDM4E (0.39) LMNAKDM4ETP53SMN1; SMN2MAPK1
SCHEMBL13046226 0.87 KDM4E (0.40) LMNAKDM4ETP53SMN1; SMN2MAPK1
SCHEMBL16433754 0.82 CCR1 (0.43) LMNACCR1CCR5CCR8L3MBTL1
SCHEMBL10354071 0.82 SMN1; SMN2 (0.50) LMNAKDM4ETP53SMN1; SMN2MAPK1
SCHEMBL13046182 0.81 KDM4E (0.42) LMNAKDM4ETP53SMN1; SMN2MAPK1
SCHEMBL10353574 0.80 CCR1 (0.40) LMNAKDM4ETP53SMN1; SMN2CCR1
SCHEMBL21215787 0.80 LMNA (0.42) LMNAKDM4ETP53SMN1; SMN2MAPK1
SCHEMBL24453781 0.80 MAPK1 (0.40) LMNAKDM4ETP53SMN1; SMN2MAPK1
SCHEMBL15977798 0.80 HPGDS (0.47) LMNAKDM4ETP53SMN1; SMN2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023080187-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE 出光興産株式会社 2023-05-11 WO disclosed
US-11552259-B1 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-01-10 US disclosed
US-20220393113-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-08 US disclosed
US-10573823-B2 Organic electroluminescent device JOLED INC (JP) 2020-02-25 US disclosed
EP-2833429-B1 ORGANIC ELECTROLUMINESCENCE ELEMENT JOLED INC (JP) 2019-09-18 EP disclosed
US-9978975-B2 Organic electroluminescence device JOLED INC (JP) 2018-05-22 US disclosed
US-9978975-B2 Organic electroluminescence device JOLED INC (JP) 2018-05-22 US disclosed
US-20160197289-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-07-07 US disclosed
US-20160197289-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-07-07 US disclosed
US-20150303380-A1 ORGANIC ELECTROLUMINESCENT DEVICE MAGNOLIA BLUE CORPORATION (JP) 2015-10-22 US disclosed
US-20150303380-A1 ORGANIC ELECTROLUMINESCENT DEVICE MAGNOLIA BLUE CORPORATION (JP) 2015-10-22 US disclosed
US-20150069351-A1 ORGANIC ELECTROLUMINESCENCE DEVICE MAGNOLIA BLUE CORPORATION (JP) 2015-03-12 US disclosed
US-7834346-B2 Nitrogenous heterocyclic derivative and organic electroluminescence device making use of the same IDEMITSU KOSAN CO., LTD. (JP) 2010-11-16 US disclosed
US-7834346-B2 Nitrogenous heterocyclic derivative and organic electroluminescence device making use of the same IDEMITSU KOSAN CO., LTD. (JP) 2010-11-16 US disclosed
US-20100108990-A1 NITROGENOUS HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2010-05-06 US disclosed
US-20100108990-A1 NITROGENOUS HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100108990-A1 NITROGENOUS HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME CYBA, NUDC, NUDT1 LMNA 936/4885KDM4E 636/4885TP53 4486/4885
US-10573823-B2 Organic electroluminescent device L1CAM, NES, EML4 LMNA 831/4885KDM4E 2954/4885TP53 4070/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.